Biontech Manufacturing Gmbh/ Pfizer Manufacturing - Germania/Belgia

7 medicamente în nomenclatorul ANM

Principale clase terapeutice

J Antiinfecțioase de uz sistemic (7)
Nume comercial DCI Concentrație Formă farmaceutică ATC
COMIRNATY concentrat pentru dispersie injectabila TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) 10 µg/doza Conc. Pt. Dispersie Injectabila J07BN01
COMIRNATY dispersie injectabila TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) 30 µg/doza Dispersie Injectabila J07BN01
COMIRNATY concentrat pentru dispersie injectabila TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) 30 µg/doza Conc. Pt. Dispersie Injectabila J07BN01
COMIRNATY concentrat pentru dispersie injectabila TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) 3µg/doza Conc. Pt. Dispersie Injectabila J07BN01
COMIRNATY ORIGINAL/OMICRON BA.1 dispersie injectabila TOZINAMERAN/RILTOZINAMERAN vacc.tipARNmCOVID-19(cu nucleozide modificate) 15µg/15µg/doza Dispersie Injectabila J07BN01
COMIRNATY ORIGINAL/OMICRON BA.4-5 concentrat pentru dispersie injectabila TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) 3µg/doza Conc. Pt. Dispersie Injectabila J07BN01
COMIRNATY ORIGINAL/OMICRON BA.4-5 dispersie injectabila TOZINAMERAN/FAMTOZINAMERAN vacc.tipARNmCOVID-19(cu nucleozide modificate) 15µg/15µg/doza Dispersie Injectabila J07BN01